P2‐215: REM sleep behavior disorder and other sleep problems in mild dementia

Arvid Rongve , Guido Alves , Dag Aarsland
Alzheimers & Dementia 4 ( 4)

2008
P2-225: The frequency of dementia with Lewy bodies in a community-based referral sample of mild dementia

Arvid Rongve , Dag Aarsland , Sabine Piepenstock Nore , Ragnhild Skogseth
Alzheimers & Dementia 4 ( 4)

2008
2008
P3-087: Neuropsychiatric correlates of CSF Tau and P-Tau in dementia

Ezra Mulugeta , Ragnhild Skogseth , Guido Alves , Emma Jones
Alzheimers & Dementia 4 ( 4)

2008
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias

Byron Creese , Clive Ballard , Dag Aarsland , Elisabet Londos
Neuroscience Letters 531 ( 1) 1 -4

4
2012
5-HT1B and other related serotonergic proteins are altered in APPswe mutation.

Walid Tajeddinn , Torbjörn Persson , Silvia Maioli , Javier Calvo-Garrido
Neuroscience Letters 594 137 -143

9
2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Willemijn J Jansen , Rik Ossenkoppele , Dirk L Knol , Betty M Tijms
JAMA 313 ( 19) 1924 -1938

745
2015
MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression.

Aleksandra K. Lebedeva , Eric Westman , Tom Borza , Mona K. Beyer
Frontiers in Aging Neuroscience 9 13

38
2017
New insights on the genetic etiology of Alzheimer’s and related dementia

Céline Bellenguez , Fahri Küçükali , Iris Jansen , Victor Andrade
medRxiv

60
2020
Personality Changes after Deep Brain Stimulation in Parkinson’s Disease

Uyen Pham , Anne-Kristin Solbakk , Inger-Marie Skogseid , Mathias Toft
Parkinson's Disease 2015 490507 -490507

30
2015
Alzheimer's disease

Clive Ballard , Serge Gauthier , Anne Corbett , Carol Brayne
The Lancet 377 ( 9770) 1019 -1031

1,265
2011
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial

Marisa Hanney , Vee Prasher , Nicola Williams , Emma L Jones
The Lancet 379 ( 9815) 528 -536

113
2012
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

Dag Aarsland , Robert Perry , Jan P. Larsen , Ian G. McKeith
The Journal of Clinical Psychiatry 66 ( 5) 633 -637

164
2005
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

Brit Mollenhauer , Lucilla Parnetti , Irena Rektorova , Milica G. Kramberger
Journal of Neurochemistry 139 290 -317

76
2016
Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.

Dag Aarsland , Robert Perry , Andrew Brown , Jan P. Larsen
Annals of Neurology 58 ( 5) 773 -776

295
2005
The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

Flora H. Duits , Charlotte E. Teunissen , Femke H. Bouwman , Pieter-Jelle Visser
Alzheimers & Dementia 10 ( 6) 713 -723

286
2014
A 5-YEAR LONGITUDINAL STUDY OF PATIENTS WITH DEMENTIA WITH LEWY BODIES AND ALZHEIMER'S DISEASE

Arvid Rongve , Hogne Sønnesyn , Ragnhild Skogseth , Dag Aarsland
Alzheimers & Dementia 10 ( 4) 261

1
2014
The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

Carla Abdelnour , Daniel Ferreira , Ketil Oppedal , Lena Cavallin
NeuroImage: Clinical 27 102333

4
2020
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)

Seyed-Mohammad Fereshtehnejad , Dorota Religa , Westman , Johan Lökk
Neuropsychiatric Disease and Treatment 9 927 -935

22
2013